|Articles|April 12, 2021
Downstream Biologics Characterization: Stability, Formulations and Aggregation Studies using Octet®
Author(s)Sartorius
Aggregates can affect the efficacy and safety of biologics. Few biophysical tools offer a combination of structural and functional assessment. Octet® systems can detect aggregates while monitoring functional activity at the formulation stage of drug development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5